Traders bought shares of UnitedHealth Group Incorporated (NYSE:UNH) on weakness during trading hours on Thursday. $200.96 million flowed into the stock on the tick-up and $127.99 million flowed out of the stock on the tick-down, for a money net flow of $72.97 million into the stock. Of all companies tracked, UnitedHealth Group had the 3rd highest net in-flow for the day. UnitedHealth Group traded down ($2.58) for the day and closed at $197.90

Several brokerages recently issued reports on UNH. Cowen and Company reiterated an “outperform” rating and issued a $220.00 price objective (up from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Morgan Stanley upped their price target on UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $215.00 price target on shares of UnitedHealth Group in a research report on Friday, August 18th. Three equities research analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $203.59.

The firm has a market cap of $191.34 billion, a price-to-earnings ratio of 23.77 and a beta of 0.63. The firm’s 50 day moving average price is $196.09 and its 200-day moving average price is $183.24.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter in the previous year, the firm earned $1.96 earnings per share. The business’s revenue was up 7.7% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were given a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 35.13%.

In other news, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the transaction, the director now directly owns 76,058 shares in the company, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders have sold a total of 76,174 shares of company stock worth $14,981,909 in the last ninety days. Insiders own 0.89% of the company’s stock.

Several large investors have recently added to or reduced their stakes in the stock. Osborn Williams & Donohoe LLC raised its stake in shares of UnitedHealth Group by 6.1% during the 3rd quarter. Osborn Williams & Donohoe LLC now owns 14,006 shares of the healthcare conglomerate’s stock valued at $2,743,000 after purchasing an additional 810 shares during the period. Curbstone Financial Management Corp raised its stake in shares of UnitedHealth Group by 74.7% during the 3rd quarter. Curbstone Financial Management Corp now owns 3,800 shares of the healthcare conglomerate’s stock valued at $744,000 after purchasing an additional 1,625 shares during the period. MPS Loria Financial Planners LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $1,254,000. Intl Fcstone Inc. bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $2,324,000. Finally, RNC Capital Management LLC raised its stake in shares of UnitedHealth Group by 0.7% during the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after purchasing an additional 13 shares during the period. Institutional investors own 86.19% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Investors Buy Shares of UnitedHealth Group Incorporated (UNH) on Weakness” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.watchlistnews.com/investors-buy-shares-of-unitedhealth-group-incorporated-unh-on-weakness/1611096.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.